SiC power modules enable high-efficiency systems for military vehicles, naval propulsion, and directed energy weapons.

Bayer has added another phase 3 trial into its registration programme for oral Factor XIa inhibitor asundexian, signalling growing confidence in a drug that generated mixed results in phase 2.

Regeneron and Teva have announced positive top-line phase 3 results from their fasinumab, as the companies chase Pfizer and Lilly in the race to market a new class of non-opioid painkillers.

The first patient has been dosed in the phase 3 IDeate-Prostate01 trial (NCT06925737), evaluating the safety and efficacy of ifinatamab deruxtecan vs docetaxel for the treatment of patients with ...

The diagram for the Griffin Silver Sword is located in the abandoned lighthouse of Lornruk, located on the far Northwestern tip of Velen. The drawbridge to the tiny island has been raised, and a ...